News | August 11, 2011

With Indian Center's New Elekta Equipment, Brain Tumors Have Nowhere to Hide

August 11, 2011 – At Mumbai, India's Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), neurosurgeons have employed Elekta SonoWand Invite in 15 patients with brain tumors since the center acquired the system in July. The integration of sophisticated intra-operative 3-D ultrasound and navigation technology in SonoWand provides both the optimal path to the tumor and –– with 3-D ultrasound –– ongoing images of the operative site, enabling the surgeon to safely remove all visible traces of the tumor.

"The goal in any tumor resection surgery is to extract the tumor –– and to extract it completely –– without causing any harm to healthy brain tissue, which is quite a challenge," said Aliasgar V. Moiyadi, MCh., associate professor and consultant neurosurgeon at ACTREC, part of Mumbai's Tata Memorial Centre. "SonoWand addresses this challenge by helping you see what you're removing, how much you've removed and how much more you could take out over and above what you could have seen with just your eyes or with the intra-operative microscope."

In a compact, single-rack solution, SonoWand Invite combines a high-performance ultrasound scanner with a built-in navigational computer and optical tracking system. The system supports several trackable instruments and accessories, such as navigators and ultrasound probes. Planning and navigation displays enable axial, coronal and sagittal views, in addition to a unique user-friendly and intuitive "anyplane view," which displays the image information in the plane of the actual surgical trajectory.

Although MRI is regarded as the premier intra-operative imaging modality for its image quality, several limitations make intra-operative MRI for brain tumors impractical, Moiyadi observed.

"An [magnetic resonance imaging] MRI system is very costly, it's large and cumbersome to work with and it takes too long to do repeated scans during surgery," he said. "Plus, MRI is not actually 'real-time,' – because you see an image, then take the next surgical step; you're not imaging and resecting simultaneously. SonoWand is an economical and effective solution."

SonoWand aids "search and destroy" mission against tumors

The SonoWand-assisted tumor resection starts with a diagnostic, multi-plane MRI, during which the patient's brain and fixed surface fiducial marks are scanned. The MRI images are imported into SonoWand and clinicians register the fiducial marks on both the images and, with an optically tracked probe, the fiducial marks on the patient's scalp. Once this registration is complete, every point in the patient's cranium will have an "address" (x,y,z) in 3-D space, which corresponds to the same point in the image.  

"When you touch the patient's head with the probe, you know that this is exactly the point on the image you're touching," he said. "And you can, by extrapolation, know that if you go, for instance, five centimeters deeper in a given plane and trajectory, you will reach a particular structure in the brain without actually seeing it, because you can follow it on the image. That is how navigation helps you plan your entry point into the brain."

The entry point indicates where the surgeon places the craniotomy. By using the navigational capability of the system, the surgeon is able to customize the craniotomy to just the right size. This avoids unnecessarily large or misplaced craniotomies. Once the craniotomy is performed and the dura mater is opened, however, cerebral spinal fluid in which the brain is suspended is released, causing the brain to shift.

"Therefore, the images that were applied preoperatively are now going to be useless because the anatomy has changed," Moiyadi explained. "At that point, we turn to the ultrasound capabilities of SonoWand, which provides a specialized probe that takes a sector view of multiple 2-D images and fuses them to afford a 3-D volume. That 3-D volume now serves as your new image with which to navigate. The best part is that the ultrasound probe is already navigating with the SonoWand computer via optical tracking and navigational spheres so we know exactly which part of the brain is being imaged by the probe."

Following the predetermined path to the tumor, the surgeon can begin to remove or "debulk" the lesion. As debulking progresses, the brain can shift again, necessitating image updates.

"Ultrasound allows us to update that information repeatedly – as many times as we want – without taking too much time," he said. "In addition, it's important to note that the SonoWand dedicated cranial ultrasound provides image quality that is far superior to any conventional ultrasound system."

Exceptional preoperative navigational capabilities and high-quality, navigated ultrasound have clearly benefited patients at ACTREC, helping ensure safer access to brain tumors and more complete removal via real-time imaging, Moiyadi observed.

"Intra-operative ultrasound – especially one like SonoWand, which is 3-D, real-time and combined with navigation – caters to all our needs, including our financial requirements," he said.

For more information: www.elekta.com/sonowand

*Approval of indications may vary between different countries. Additional regulatory clearances may be required in some markets.

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Image courtesy of Loyola Medicine

News | Pediatric Imaging | May 29, 2018
A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be...
Samsung Receives FDA Clearance for Premium Ultrasound System RS85
Technology | Ultrasound Imaging | May 07, 2018
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced the Samsung RS85 ultrasound system has received U....
3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac. This is a baby ultrasound, also referred to as fetal ultrasound or prenatal ultrasound.

3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac.

Feature | Ultrasound Women's Health | May 07, 2018
Below is a collection of prenatal ultrasound images from the ITN archive.
Esaote Change of Ownership Completed
News | Ultrasound Imaging | April 30, 2018
The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company...
Overlay Init